3 completed, 2 unknown, 1 terminated, 1 withdrawn. 7 Phase 2, 3 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 3, Unknown 2, Terminated 1, Withdrawn 1 |
| Phase 3 | 3 | Unknown 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow Blepharoptosis: new trials by email Literature Review of Blepharoptosis trials Research Report on Blepharoptosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| LEV102 Topical Gel in Acquired Blepharoptosis LEV102 1.0%, LEV102 2.0%, Vehicle - Acquired Blepharoptosis | Phase 1 / Phase 2 | Completed | Levation Pharma, Ltd. | 33 | 2023-02-23 | 2024-11-13 |
| Fibrin Sealant in Eyelid Surgery Tisseel - Blepharoptosis, Ecchymosis; Eyelid | Phase 2 / Phase 3 | Unknown | University of Calgary | 30 | 2022-05-01 | 2022-05-03 |
| Treatment of Ptosis to Muscular Dystrophy Oculopharyngeal by Myoblast Autologous Graft Myoblast autologous graft - Muscular Dystrophy, Oculopharyngeal, Ptosis | Phase 2 / Phase 3 | Terminated | University Hospital, Caen | 1 | 2019-11-14 | 2020-11-25 |
| Bupivacaine Epiphora Trial 0.75% bupivacaine - Epiphora, Ptosis | Phase 2 | Withdrawn | McMaster University | 2015-04-01 | 2022-08-25 | |
| Phase 2 Study of XAF5 (XOPH5) Ointment for Reduction of Excess Eyelid Fat (Steatoblepharon) XOPH5 Ointment, Placebo - Lower Eyelid Steatoblepharon (Excess Eyelid Fat) | Phase 2 | Completed | Topokine Therapeutics, Inc. | 90 | 2014-09-01 | 2016-02-08 |
| Safety and Efficacy Study of RVL-1201 in Acquired Blepharoptosis RVL-1201, RVL-1201 Vehicle Placebo - Blepharoptosis | Phase 1 / Phase 2 | Completed | RVL Pharmaceuticals, Inc. | 46 | 2013-05-01 | 2021-11-26 |
| Bupivacaine Injection of Eye Muscles to Treat Strabismus Bupivacaine - Strabismus, Esotropia | Phase 2 / Phase 3 | Unknown | Smith-Kettlewell Eye Research Institute | 120 | 2012-04-01 | 2019-09-23 |
Cutis Laxa (1) · Diplopia (1) · Ecchymosis (1) · Esotropia (1) · Exotropia (1) · Graves Disease (1) · Lacrimal Apparatus Diseases (1) · Muscular Dystrophy, Oculopharyngeal (1) · Strabismus (1)
Eye Diseases (7) · Eyelid Diseases (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Nervous System Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Autoimmune Diseases (1) · Blood Coagulation Disorders (1) · Connective Tissue Diseases (1) · Cranial Nerve Diseases (1) · Endocrine System Diseases (1) · Exophthalmos (1) · Goiter (1) · Hematologic Diseases (1)
Bupivacaine (2) · Fibrin Tissue Adhesive (1)
Levation Pharma, Ltd. (1) · McMaster University (1) · RVL Pharmaceuticals, Inc. (1) · Smith-Kettlewell Eye Research Institute (1) · Topokine Therapeutics, Inc. (1) · University Hospital, Caen (1) · University of Calgary (1)
United States (5) · France (1)
Alan B Scott, MD (1) · Albert Y Wu, MD PhD (1) · Chuck Slonim, MD (1) · Frederic MF Mouriaux, PhD (1) · Houman D Hemmati, MD PhD (1) · Joel M Miller, PhD (1) · Karim Punja, MD (1) · Michael S. Singer, MD, PhD (1) · Olivier BO Boyer, PhD (1) · Sophie PS Perie, PhD (1)
2015 (1)